COMP <GO>
PG vs TSLA // REVENUE GROWTH (YOY)
Procter & Gamble Company (The) (NYSE) VS. Tesla, Inc. (NASDAQ) • 15-METRIC TALLY: PG 11
— TSLA 4
▲ REVENUE GROWTH (YOY) LEADER: TSLA
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
revenue-growth
0.30%
LAST: $399.81 (-0.87%) • MKT CAP: $1.58T
revenue-growth
8.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PG VS. TSLA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PG | TSLA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 51.20% | 19.29% | +31.91 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 25.40% | 3.39% | +22.01 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.2x | 199.0x | -182.84 | PG | /valuation <GO> |
| Free Cash Flow Yield | 3.77% | 0.21% | +3.56 | PG | /fcf-yield <GO> |
| Operating Margin | 24.30% | 3.35% | +20.95 | PG | /operating-margins <GO> |
| Net Profit Margin | 19.00% | 3.11% | +15.89 | PG | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 0.30% | 8.30% | -8.00 | TSLA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.65% | 0.00% | +2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.59 | 15.35 | -9.76 | TSLA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 8.72% | -2.22 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.7 | 60.9 | +1.82 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 1.89 | -1.02 | TSLA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.7x | 174.4x | -152.73 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $372.21B | $1.58T | -$1.21T | TSLA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PG REV | TSLA REV | PG GROSS % | TSLA GROSS % | PG FCF | TSLA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $84.28B | $94.83B | 51.2% | 18.0% | $14.04B | $6.22B |
| FY 2024 | $84.04B | $97.69B | 51.4% | 17.9% | $16.52B | $3.58B |
| FY 2023 | $82.01B | $96.77B | 44.0% | 18.3% | $13.16B | $4.36B |
| FY 2022 | — | $81.46B | — | 25.6% | — | $7.57B |
| FY 2021 | — | $53.82B | — | 25.3% | — | $5.01B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PG // BETA 0.87
TSLA // BETA 1.89